Celz will be looking to partner up and or sell it's patented IP's. The patents can fetch huge validations. And with the caverstem Intellectual property up and running it is a potential target for a huge buyout? You must remember Intellectual property's have value not just in current sales but potential growth factor too. Imagine every urologist adapting this into their business worldwide? Huge value, forthcoming? Being early in a stock can sometimes hurt, but what hurts even more is turning your back on something you invested in and to watch it succeed without you?